Read + Share
Amedeo Smart
Independent Medical Education
Kong Y, Hong L, Xu XC, Chen YF, et al. The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials. PLoS One 2024;19:e0301931.PMID: 38683829
Email
LinkedIn
Facebook
Twitter
Privacy Policy